The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Open accessAbstract
BACKGROUND: Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer. METHODS: Data from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models. FINDINGS: 13 226 controls and 7911 women with invasive ovarian cancer were included in this analysis. 818 and 738, respectively, reported a history of endometriosis. 1907 women with borderline ovarian cancer were also included in the analysis, and 168 of these reported a history of endometriosis. Self-reported endometriosis was associated with a significantly increased risk of clear-cell (136 [20·2%] of 674 cases vs 818 [6·2%] of 13 226 controls, odds ratio 3·05, 95% CI 2·43-3·84, p<0·0001), low-grade serous (31 [9·2%] of 336 cases, 2·11, 1·39-3·20, p<0·0001), and endometrioid invasive ovarian cancers (169 [13·9%] of 1220 cases, 2·04, 1·67-2·48, p<0·0001). No association was noted between endometriosis and risk of mucinous (31 [6·0%] of 516 cases, 1·02, 0·69-1·50, p=0·93) or high-grade serous invasive ovarian cancer (261 [7·1%] of 3659 cases, 1·13, 0·97-1·32, p=0·13), or borderline tumours of either subtype (serous 103 [9·0%] of 1140 cases, 1·20, 0·95-1·52, p=0·12, and mucinous 65 [8·5%] of 767 cases, 1·12, 0·84-1·48, p=0·45). INTERPRETATION: Clinicians should be aware of the increased risk of specific subtypes of ovarian cancer in women with endometriosis. Future efforts should focus on understanding the mechanisms that might lead to malignant transformation of endometriosis so as to help identify subsets of women at increased risk of ovarian cancer. FUNDING: Ovarian Cancer Research Fund, National Institutes of Health, California Cancer Research Program, California Department of Health Services, Lon V Smith Foundation, European Community's Seventh Framework Programme, German Federal Ministry of Education and Research of Germany, Programme of Clinical Biomedical Research, German Cancer Research Centre, Eve Appeal, Oak Foundation, UK National Institute of Health Research, National Health and Medical Research Council of Australia, US Army Medical Research and Materiel Command, Cancer Council Tasmania, Cancer Foundation of Western Australia, Mermaid 1, Danish Cancer Society, and Roswell Park Alliance Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“endometrioid cancer (OR 2.21)”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“It is becoming clear that epigenetics and genomic instability associated with the particular microenvironment of endometriosis characterized by oxidative stress, inflammatory process and high estrogen levels contribute to the process of malignant transformation of endometriosis (Pearce et al., 2012, Nezhat et al., 2014).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al., 2012
In the citing paper
“and low-grade serous invasive ovarian cancers (OR 2.21).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. (2012), concluded that self-reported endometriosis was associated with significantly increased risk for CCC [odds ratio (OR) 3.05]”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. summarized 13 case-control studies and reported the highest odds ratio of 3.05 for clear cell carcinoma, followed by LG-serous (2.11) and endometrioid carcinoma (2.04) in patients with endometriosis [9].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Malignant transformation of ovarian endometriosis has been well documented.”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“In population-based studies, the incidence of ovarian cancer in patients with a history of ovarian endometriosis is 1.35-1.49times greater compared with those without this history [9,10].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Of these, we observed associations with multiple diseases or traits, including epithelial ovarian cancer21, low-density lipoprotein cholesterol22, coronary heart disease23, luteinizing hormone and follicle-stimulating hormone levels, and age at onset for menopause24.”
From Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism (2017) · cites this paper as [21]
In the citing paper
“Most recently, in a study of 13 226 controls and 7911 women with invasive ovarian cancer, self-reported endometriosis was associated with a significantly increased risk of clear-cell, low-grade serous, and endometrioid invasive ovarian cancers.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“No association was noted between endometriosis and risk of mucinous or high-grade serous invasive ovarian cancer or borderline tumors of either subtype.118”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“Endometriosis and ovarian cancer have been linked by a number of studies.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“which have been (suggested to be) associated with endometriosis or its constituting symptoms in epidemiologic studies (51–54).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,890
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationEskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,099
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Self-citationCancer risk after a hospital discharge diagnosis of endometriosis
Brinton, L. A., Gridley, G., Persson, I. R., Baron, J. A., & Bergqvist, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70550-7 · Cited by 549
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Ness, R. B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.3.217 · Cited by 425
Self-citationRisk of cancer after use of fertility drugs with in-vitro fertilisation
Venn, A., Watson, L., Bruinsma, F., Giles, G. G., & Healy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05203-4 · Cited by 368
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
Melin, A., Sparén, P., Persson, I., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei462 · Cited by 306
Cited by
Sorted by citations
Items 401–500 of 946
Grzywa, R., Gorodkiewicz, E., Burchacka, E., Lesner, A., Laudański, P., Łukaszewski, Z., & Sieńczyk, M. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.08.029 · Cited by 20
Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy
Okumura, T., Muronosono, E., Tsubuku, M., Terao, Y., Takeda, S., & Maruyama, M. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0449-1 · Cited by 19
Effects of risk factors for ovarian cancer in women with and without endometriosis
Phung, M. T., Muthukumar, A., Trabert, B. L., Webb, P. M., Jordan, S. J., Terry, K. L., Cramer, D. W., Titus, L. J., Risch, H. A., Doherty, J. A., et al. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.07.019 · Cited by 19
Self-citationHarris, H. R., Peres, L. C., Johnson, C. E., Guertin, K. A., Beeghly, A., Bandera, E. V., Bethea, T. N., Joslin, C. E., Wu, A. H., Moorman, P. G., et al. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005191 · Cited by 19
Self-citationTakeyama, N., Sasaki, Y., Ueda, Y., Tashiro, Y., Tanaka, E., Nagai, K., Morioka, M., Ogawa, T., Tate, G., Hashimoto, T., et al. (2024) · Japanese Journal of Radiology · doi:10.1007/s11604-024-01545-z · Cited by 21
Ovarian clear cell carcinoma: open questions on the management and treatment algorithm
Rosso, R., Turinetto, M., Borella, F., Chopin, N., Méeus, P., Lainé, A., Ray-Coquard, I. L., Saux, O. L., & Ferraioli, D. (2025) · The Oncologist · doi:10.1093/oncolo/oyae325 · Cited by 21
Lü, B., Chen, Q., Zhang, X., & Cheng, L. (2016) · Diagnostic Pathology · doi:10.1186/s13000-016-0496-0 · Cited by 19
Ovarian cancer epidemiology in the era of collaborative team science
Cannioto, R. A., Trabert, B. L., Poole, E. M., & Schildkraut, J. M. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0862-6 · Cited by 19
Self-citationZhang, H., Lu, J., Lu, Y., Zhou, J., Wang, Z., Liu, H., & Xu, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177520 · Cited by 19
Huang, T., Townsend, M. K., Wentzensen, N., Trabert, B. L., White, E., Arslan, A. A., Weiderpass, E., Buring, J. E., Clendenen, T. V., Giles, G. G., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0734 · Cited by 19
Endometriosis and Endometriosis-Associated Ovarian Cancer (EAOC)
Pejovic, T. B., Thisted, S., White, M., & Nezhat, F. R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38474-6_5 · Cited by 20
Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies
Peres, L. C., Townsend, M. K., Birmann, B. M., Conejo-Garcia, J. R., Kim, Y., Kubzansky, L. D., Magpantay, L. I., Martı́nez-Maza, O., & Tworoger, S. S. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1390 · Cited by 19
Association Between Endometriosis and Prognosis of Ovarian Cancer: An Updated Meta-Analysis
Chen, P., & Zhang, C.-Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.732322 · Cited by 19
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
Li, H., Qiang, J., Xia, G. L., Zhao, S. H., Feng, H., Cai, S., Feng, F., & Fu, A. Y. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0154-2 · Cited by 19
Al-Badawi, I. A., Abu‐Zaid, A., Alomar, O., Alsabban, M., Alsehaimi, S. O., Alqarni, S. M. S., Alabdrabalamir, S., Baradwan, S., Baalharith, M. A., Al-Odaini, A. A., et al. (2024) · Current Oncology · doi:10.3390/curroncol31010032 · Cited by 19
Chen, B., Zhao, L., Yang, R., & Xu, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1329133 · Cited by 18
Risk Factors for Ovarian Cancers With and Without Microsatellite Instability
Segev, Y., Pal, T., Rosen, B. P., McLaughlin, J. R., Sellers, T. A., Risch, H. A., Zhang, S., Ping, S., Narod, S. A., & Schildkraut, J. M. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31829a5527 · Cited by 18
Self-citationRetractedSchildkraut, J. M., Iversen, E. S., Akushevich, L., Whitaker, R. S., Bentley, R. C., Berchuck, A., & Marks, J. R. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0192 · Cited by 18
Self-citationKim, S., Wang, M., Tyrer, J. P., Jensen, A., Wiensch, A., Liu, G., Lee, A. W., Ness, R. B., Salvatore, M., Tworoger, S. S., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32029 · Cited by 18
Self-citationSon, J., Yoon, S., Kim, S., Kong, T., Paek, J., Chang, S., & Ryu, H. (2019) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2019.62.1.27 · Cited by 18
Malignant extra‐ovarian endometriosis: A case series of ten patients and review of the literature
Poon, C., & Rome, R. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13178 · Cited by 18
Epithelial Tumors of the Ovary
Seidman, J. D., Ronnett, B. M., Shih, I., Cho, K. R., & Kurman, R. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6_14 · Cited by 19
Women's Reproductive History Before the Diagnosis of Incident Endometriosis
Louis, G. B. B., Backonja, U., Schliep, K., Sun, L., Peterson, C., & Chen, Z. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5712 · Cited by 16
The origin of endometriosis-associated ovarian cancer from uterine neoplastic lesions
Garavaglia, E., Sigismondi, C., Ferrari, S. M., & Candiani, M. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.11.006 · Cited by 18
Wu, R., Veras, E. F. T., Lin, J. H., Gerry, E., Bahadirli-Talbott, A., Baras, A. S., Ayhan, A., Shih, I., & Wang, T. (2017) · Molecular Case Studies · doi:10.1101/mcs.a001693 · Cited by 18
Clear cell cancer of the ovary
Penson, R. T., Dizon, D. S., & Birrer, M. J. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328363e0c7 · Cited by 17
Akashi, K., Nagashima, Y., Tabata, T., & Oda, H. (2021) · Molecular and Clinical Oncology · doi:10.3892/mco.2021.2321 · Cited by 18
Soroczyńska, K., Zaręba, Ł., Długołęcka, M., & Czystowska, M. (2022) · Cells · doi:10.3390/cells11091483 · Cited by 17
Non-thermal plasma prevents progression of endometriosis in mice
Ishida, C., Mori, M., Nakamura, K., Tanaka, H., Mizuno, M., Hori, M., Iwase, A., Kikkawa, F., & Toyokuni, S. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1211273 · Cited by 17
Park, H. K., Schildkraut, J. M., Alberg, A. J., Bandera, E. V., Barnholtz‐Sloan, J. S., Bondy, M. L., Crankshaw, S., Funkhouser, E. M., Moorman, P. G., Peters, E. S., et al. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1082-4 · Cited by 17
Self-citationNakamura, N., Terai, Y., Nunode, M., Kokunai, K., Konishi, H., Taga, S., Nakamura, M., Yoo, M., Hayashi, M., Yamashita, Y., et al. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00652-5 · Cited by 17
Tirodkar, T. S., Budiu, R. A., Elishaev, E., Zhang, L., Mony, J. T., Brozick, J., Edwards, R. P., & Vlad, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102409 · Cited by 17
Polypoid endometriosis mimicking invasive cancer in an obese, postmenopausal tamoxifen user
Jaegle, W. T., Barnett, J. C., Stralka, B. R., & Chappell, N. P. (2017) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2017.10.004 · Cited by 17
Prevention of Epithelial Ovarian CancerPreprint
Sellers, T. A., Peres, L. C., Hathaway, C. A., & Tworoger, S. S. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038216 · Cited by 18
Ishizaka, A., Taguchi, A., Tsuruga, T., Maruyama, M., Kawata, A., Miyamoto, Y., Tanikawa, M., Ikemura, M., Sone, K., Mori, M., et al. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01917-5 · Cited by 17
Sheikhvatan, M., Chaichian, S., & Moazzami, B. (2019) · MicroRNA · doi:10.2174/2211536608666190917152104 · Cited by 16
IL6, IL8, and IL10 in the distinction of malignant ovarian neoplasms and endometriomas
Crispim, P. C. A., Jammal, M. P., Antão, P. K. A., Micheli, D. C., Tavares‐Murta, B. M., Murta, E. F. C., & Nomelini, R. S. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13309 · Cited by 16
Ovarian Cancer: Molecular Classification and Targeted Therapy
Ravindran, F., & Choudhary, B. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95967 · Cited by 16
Clear cell carcinoma arising from a uterus‐like mass
Nakakita, B., Abiko, K., Mikami, Y., Kido, A., Baba, T., Yoshioka, Y., Yamaguchi, K. D., Matsumura, N., & Konishi, I. (2014) · Pathology International · doi:10.1111/pin.12218 · Cited by 16
Ovarian Endometrioma: What the Patient Needs
(2014) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2014.01.011 · Cited by 16
Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention
Karnezis, A. N., & Cho, K. R. (2017) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000312 · Cited by 17
Endometriosis — insights into a multifaceted entity
Amălinei, C., Păvăleanu, I., Lozneanu, L., Balan, R. A., Giuşcă, S. E., & Căruntu, I.-D. (2018) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2018.0013 · Cited by 17
Schildkraut, J. M., Peres, L. C., Bethea, T. N., CAMACHO, F. T., Chyn, D., Cloyd, E. K., Bandera, E. V., Beeghly-Fadiel, A. C., Lipworth, L. P., Joslin, C. E., et al. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01199-7 · Cited by 16
Self-citationOvarian cancer prevention and screening
Gentry‐Maharaj, A., Griffin, M., & Menon, U. (2018) · Wiley eBooks · doi:10.1002/9781118990957.ch23 · Cited by 16
Self-citationWilczyński, J. R., Szubert, M., Paradowska, E., & Wilczyński, M. (2022) · Cancers · doi:10.3390/cancers15010111 · Cited by 16
Chen, S., Lu, H., Jiang, S., Li, M., Weng, H., Zhu, J., Zhang, T., Wang, Y., Zhao, W., Wu, D., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11048-1 · Cited by 15
Vaginal Bacteria Elicit Acute Inflammatory Response in Fallopian Tube Organoids
Yu, B., Nguyen, E. B., McCartney, S., Strenk, S., Valint, D., Liu, C., Haggerty, C., & Fredricks, D. N. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01350-5 · Cited by 15
Does the Presence of Endometriosis Affect Prognosis of Ovarian Cancer?
Dinkelspiel, H. E., Matrai, C. E., Pauk, S. J., Pierre-Louis, A., Chiu, Y.-L., Gupta, D., Caputo, T. A., Ellenson, L. H., & Holcomb, K. (2016) · Cancer Investigation · doi:10.3109/07357907.2016.1139716 · Cited by 15
Andersen, C. L., Boisen, M. M., Sikora, M. J., Ma, T., Tseng, G. C., Suryawanshi, S., Vlad, A., Elishaev, E., Edwards, R. P., & Oesterreich, S. (2018) · Hormones and Cancer · doi:10.1007/s12672-018-0350-9 · Cited by 15
Wang, J., Zhao, S., Wang, F., Wang, J., & Zhang, Y. (2019) · Medical Science Monitor · doi:10.12659/msm.915911 · Cited by 15
Amano, T., Chano, T., Yoshino, F., Kimura, F., & Murakami, T. (2019) · Healthcare · doi:10.3390/healthcare7030094 · Cited by 16
Endometriosis and ovarian cancer risk, an epigenetic connection
Brunty, S., Mitchell, B. L., Zgheib, N. B., & Santanam, N. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2449 · Cited by 15
Zhu, R., Nasu, K., Hijiya, N., Yoshihashi, M., Hirakawa, T., Aoyagi, Y., & Narahara, H. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00604-4 · Cited by 15
Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro
Rogers‐Broadway, K., Chudasama, D. Y., Pados, G., Tsolakidis, D., Goumenou, A. G., Hall, M., & Karteris, E. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3531 · Cited by 15
Endometriosis and ovarian cancer
Vercellini, P., Somigliana, E., Buggio, L., Bolis, G., & Fedele, L. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70198-5 · Cited by 15
Falconer, H., Sundqvist, J., Xu, H., Vodolazkaia, A., Fassbender, A., Kyama, C. M., Bokor, A., & D’Hooghe, T. M. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.08.013 · Cited by 14
Li, G. H., Akatsuka, S., Chew, S. H., Jiang, L., Nishiyama, T., Sakamoto, A., Takahashi, T., Futakuchi, M., Suzuki, H., Sakumi, K., et al. (2017) · Pathology International · doi:10.1111/pin.12598 · Cited by 14
Epidemiology and Risk Factors for Ovarian Cancer
Singla, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-3438-2_17 · Cited by 14
Age at last birth and risk of developing epithelial ovarian cancer: a meta-analysis
Wu, Y., Sun, W., Xin, X., Wang, W., & Zhang, D. (2019) · Bioscience Reports · doi:10.1042/bsr20182035 · Cited by 14
DNA methylation subtypes for ovarian cancer prognosis
Yin, L., Zhang, N., & Yang, Q. F. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13056 · Cited by 14
International trends in ovarian cancer incidence from 1973 to 2012
Hao, W., Zhang, Y., Li, Z., Zhang, E., Gao, S., Yin, C., & Yue, W. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-05967-2 · Cited by 14
Rodriguez, M., Kang, E. Y., Farrington, K., Cook, L. S., Le, N. D., Karnezis, A. N., Lee, C., Nelson, G. S., Terzić, T., Lee, S., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001798 · Cited by 14
Nero, C., Romito, I., Spadola, S., Romito, A., Turco, L. C., Cosentino, F., Ninno, M. D., Catena, U., Nardone, A. D. C., Moroni, R., et al. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.08.032 · Cited by 14
Endometriosis and gynaecological cancers: molecular insights behind a complex machinery
Větvička, V., Fiala, L., Garzon, S., Buzzaccarini, G., Terzić, M., & Laganà, A. S. (2021) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2021.111276 · Cited by 14
Tanaka, T., Takehara, K., Yamashita, N., Okazawa‐Sakai, M., Kuraoka, K., Teramoto, N., Taguchi, K., Yamashiro, K., Kato, H., Mizunoe, T., et al. (2022) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2022.33.e67 · Cited by 14
Oncolytic virotherapy for ovarian cancer
McFadden, D., Li, L., Rahman, Shepherd, & Tong, T. (2012) · Oncolytic Virotherapy · doi:10.2147/ov.s31626 · Cited by 14
Menstrual pain and epithelial ovarian cancer risk
Babić, A., Cramer, D. W., Titus, L. J., Tworoger, S. S., & Terry, K. L. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0463-6 · Cited by 14
Self-citationL’endométriose est-elle une lésion pré-cancéreuse ? Perspectives et implications cliniques
Chene, G., Caloone, J., Moret, S., Bail-Carval, K. L., Chabert, P., Beaufils, E., Mellier, G., & Lamblin, G. (2016) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2016.01.001 · Cited by 15
Kollara, A., Shathasivam, P., Park, S., Ringuette, M. J., & Brown, T. J. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105498 · Cited by 14
Ovarian cancer screening in the general population
Mathis, J., Jellouli, M. A., Sabiani, L., Fest, J., Blache, G., & Mathevet, P. (2019) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2019-0038 · Cited by 14
Markedly increased risk of malignancies in women with endometriosis
Eoh, K. J., Han, M., Kim, E. H., Jung, I., & Kim, Y. T. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.01.019 · Cited by 14
Risk of Iron Deficiency in Women With Endometriosis: A Population-Based Prospective Cohort Study
Gete, D. G., Doust, J. A., Mortlock, S., Montgomery, G. W., & Mishra, G. D. (2024) · Women s Health Issues · doi:10.1016/j.whi.2024.03.004 · Cited by 13
Establishment of endometriotic models: the past and future
Gu, Z., Jia, S., & Leng, J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000885 · Cited by 13
Poli‐Neto, O. B., Carlos, D., Favaretto, A. L., Silva, J. C. R. E., Meola, J., & Tiezzi, D. G. (2021) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2021.103307 · Cited by 13
Kai, K., Joshi, N., Burns, G. W., Hrbek, S. M., Vegter, E. L., Ochoa-Bernal, M. A., Song, Y., Moldovan, G. E., Sempere, L. F., Miyadahira, E. H., et al. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01253-5 · Cited by 13
[Endometriosis as a risk factor for ovarian cancer].
Vargas-Hernández, V. M. (2013) · PubMed · Cited by 13
Casey, M. J., Bewtra, C., Lynch, H. T., Snyder, C., Stacy, M., & Watson, P. A. (2013) · Familial Cancer · doi:10.1007/s10689-013-9651-x · Cited by 13
Malignant transformation of superficial peritoneal endometriosis lesion
Marchand, E., Héquet, D., Thoury, A., & Barranger, E. (2013) · BMJ Case Reports · doi:10.1136/bcr-2012-007730 · Cited by 13
Subfertility: What the Radiologist Needs to Know
Vickramarajah, S., Stewart, V. R., van Ree, K., Hemingway, A. P., Crofton, M. E., & Bharwani, N. (2017) · Radiographics · doi:10.1148/rg.2017170053 · Cited by 13
Xu, X., Wang, X., Zhang, H., Liu, M.-Y., & Chen, Q. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170720 · Cited by 13
Ovarian endometriosis: risk factor analysis and prediction of malignant transformation
Zhou, Y., & Hua, K. (2018) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2018.74902 · Cited by 13
Endometriosis and ovarian cancer: Their association and relationship
Esteve, E. B., Pérez-Arguedas, M., Muratori, G. A. G., Acién, M., & Acién, P. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2019.100053 · Cited by 13
Endometriosis Malignant Transformation Review: Rhabdomyosarcoma Arising From an Endometrioma
NEZHAT, C. R., Vu, M., Vang, N., Ganjoo, K. N., Karam, A., Folkins, A. K., Nezhat, A. A., & Nezhat, F. R. (2019) · JSLS Journal of the Society of Laparoscopic & Robotic Surgeons · doi:10.4293/jsls.2019.00038 · Cited by 13
NAT2 gene polymorphisms and endometriosis risk: A PRISMA-compliant meta-analysis
Wei, Z., Zhang, M., Zhang, X., Yi, M., Xia, X., & Fang, X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0227043 · Cited by 13
Huang, C., Chang, W.-H., Huang, H., Guo, C., Chou, Y., Huang, N., Lee, W.-L., & Wang, P. (2020) · Clinical Epidemiology · doi:10.2147/clep.s199349 · Cited by 13
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association
Khoja, L., Weber, R. P., Webb, P. M., Jordan, S. J., Muthukumar, A., Chang‐Claude, J., Fortner, R. T., Jensen, A., Kjær, S. K., Risch, H. A., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.10.088 · Cited by 13
Self-citationTalia, K. L., Arora, R., & McCluggage, W. G. (2021) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000785 · Cited by 13
Usset, J. L., Raghavan, R., Tyrer, J. P., McGuire, V. M., Sieh, W., Webb, P. M., Chang‐Claude, J., Rudolph, A., Anton‐Culver, H., Berchuck, A., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1039 · Cited by 13
Self-citationIt Is the Time to Treat Endometriosis Based on Pathophysiology.
Chaichian, S. (2019) · Europe PMC (PubMed Central) · Cited by 12
Nishijima, A., Oda, K., Hasegawa, K., Koso, T., Asada, K., Ikeda, Y., Taguchi, A., Maeda, D., Nagae, G., Tsuji, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69796-4 · Cited by 12
Ota, Y., Ota, K., Takahashi, T., Suzki, S., Sano, R., Ota, I., Moriya, T., & Shiota, M. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-02105-1 · Cited by 12
Virani, S., Baiocchi, G., Bowtell, D. D. L., Cabasag, C. J., Cho, K. R., Fortner, R. T., Fujiwara, K., Kim, J., Köbel, M., Kurtz, J., et al. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab043 · Cited by 12
Self-citationTubal Endometriosis: From Bench to Bedside, A Scoping Review
Prodromidou, A., Kathopoulis, N., Zacharakis, D., Grigoriadis, T., Chatzipapas, I., & Πρωτόπαπας, Α. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030362 · Cited by 12
Nakagawa, M., Matsumoto, T., Yokoi, A., Hashimura, M., Oguri, Y., Konno, R., Ishibashi, Y., Ito, T., Ohhigata, K., Harada, Y., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13503 · Cited by 12
Endometrioseassoziierte Tumorerkrankungen des Ovars
Schmidt, D., & Ulrich, U. A. (2014) · Der Pathologe · doi:10.1007/s00292-014-1949-4 · Cited by 12
Kelemen, L. E., Terry, K. L., Goodman, M. T., Webb, P. M., Bandera, E. V., McGuire, V. M., Rossing, M. A., Wang, Q., Dicks, E., Tyrer, J. P., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400068 · Cited by 12
Self-citationDistinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis
Zhang, C., Wang, X., Anaya, Y., Parodi, L., Cheng, L., Anderson, M. L., & Hawkins, S. M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31768 · Cited by 12
Alldredge, J. K., Serna-Gallegos, T. R., Gallegos, N., VanLeer, J. P., Chang, J. J., Ziogas, A., Goreal, W., & Randall, L. M. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.10.008 · Cited by 12
Self-citationMSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
Eppich, S., Kühn, C., Schmoeckel, E., Mayr, D. C., Mahner, S., Jeschke, U., Gallwas, J. K. S., & Heidegger, H. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124529 · Cited by 12
Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications.
Dubeau, L. (2015) · PubMed · doi:10.3978/j.issn.2218-676x.2015.01.06 · Cited by 12
Metadata
- Authors
- Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L. R., Carney, M. E., Goodman, M. T., Moysich, K., Kjaer, S. K., Hogdall, E., Jensen, A., Goode, E. L., Fridley, B. L., Larson, M. C., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Vitonis, A. F., Titus, L. J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S. J., Anderson, A. R., Brueggmann, D., Fasching, P. A., Gayther, S. A., Huntsman, D. G., Menon, U., Ness, R. B., Pike, M. C., Risch, H., Wu, A. H., & Berchuck, A.
- Affiliations
- University of Southern California (US)
- Fred Hutch Cancer Center (US)
- Georgetown University Medical Center (US)
- QIMR Berghofer Medical Research Institute (AU)
- German Cancer Research Center (DE)
- University of Hawaiʻi at Mānoa (US)
- Roswell Park Comprehensive Cancer Center (US)
- Danish Cancer Society (DK)
- Mayo Clinic (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Dartmouth College (US)
- University of California, Irvine (US)
- University of North Carolina at Chapel Hill (US)
- University College London (GB)
- University of California, Los Angeles (US)
- Yale University (US)
- Corresponding author
- Pearce, Celeste Leigh
- ORCID
- Pearce, Celeste Leigh
- Lee, Alice
- Near, Aimee M
- Webb, Penelope M
- Nagle, Christina M
- Doherty, Jennifer A
- Wicklund, Kristine G
- Wilkens, Lynne R
- Goodman, Marc T
- Moysich, Kirsten
- Jensen, Allan
- Goode, Ellen L
- Fridley, Brooke L
- Larson, Melissa C
- Schildkraut, Joellen M
- Cramer, Daniel W
- Terry, Kathryn L
- Titus, Linda J
- Ziogas, Argyrios
- Brewster, Wendy
- Ramus, Susan J
- Fasching, Peter A
- Gayther, Simon A
- Menon, Usha
- Pike, Malcolm C
- Risch, Harvey
- Wu, Anna H
- Berchuck, Andrew
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 13
- Issue
- 4
- Pages
- 385-394
- ISSN
- 1470-2045 (ISSN-L)
- PMC
- PMC3664011
- OpenAlex
- W2125681453
- Cited by
- 939
- References
- 43
- Citations by year
- 2026: 47 · 2025: 53 · 2024: 46 · 2023: 64 · 2022: 44 · 2021: 84 · 2020: 88 · 2019: 77 · 2018: 71 · 2017: 83 · 2016: 68 · 2015: 65 · 2014: 55 · 2013: 68 · 2012: 26
- FWCI
- 79.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- California Breast Cancer Research Program (0001389V20170, 2110200)
- Seventh Framework Programme (HEALTH-F2-2009-223175)
- University of South China
- National Institutes of Health (5R01 CA074850, CA14089, CA17054, CA58860, CA61132, CA92044, N01 CN67001, N01 PC35137, N01 PC67010, P50 CA105009, P50 CA136393, PSA 042205, R01 CA112523, R01 CA122443, R01 CA126841, R01 CA136891, R01 CA54419, R01 CA58598, R01 CA61107, R01 CA76016, R01 CA87538, R01 CA95023, R03 CA113148)
- Medical Research and Materiel Command (DAMD 170110729, DAMD17-02-1-0669, W81XWH0610220, W81XWH1010280)
- Oak Foundation
- Lon V. Smith Foundation (LVS 39420)
- California Department of Public Health (050E8709)
- Roswell Park Alliance Foundation, Roswell Park Cancer Institute
- Kræftens Bekæmpelse
- Deutsches Krebsforschungszentrum
- National Health and Medical Research Council (199600)
- Cancer Council Tasmania
- American University of Sharjah
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- endometriosis, ovarian cancer, histological subtypes, ovarian clear cell carcinoma, low-grade serous ovarian cancer, endometrioid ovarian cancer, mucinous ovarian carcinoma, high-grade serous ovarian cancer, borderline ovarian tumors, cancer risk factors, oral contraceptive use, parity, tumor stage and grade, Ovarian Cancer Association Consortium
- MeSH terms
- Aged, Aged, 80 and over, Endometriosis, Ethnicity, Female, Humans, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
